{"id":8374,"date":"2018-11-12T12:59:59","date_gmt":"2018-11-12T20:59:59","guid":{"rendered":"https:\/\/vccf.org\/?p=8374"},"modified":"2025-01-29T07:48:34","modified_gmt":"2025-01-29T07:48:34","slug":"amgen-foundation-pledges-500000-in-relief-to-victims-of-ventura-and-los-angeles-county-wildfires","status":"publish","type":"post","link":"https:\/\/vccf.org\/pt\/amgen-foundation-pledges-500000-in-relief-to-victims-of-ventura-and-los-angeles-county-wildfires\/","title":{"rendered":"A Funda\u00e7\u00e3o Amgen promete $500 000 para ajudar as v\u00edtimas dos inc\u00eandios florestais nos condados de Ventura e Los Angeles"},"content":{"rendered":"<p><!--more--><\/p>\n<p><em>Read the full story below or on the PR Newswire <a href=\"https:\/\/www.prnewswire.com\/news-releases\/amgen-foundation-pledges-500-000-in-relief-to-victims-of-ventura-and-los-angeles-county-wildfires-300748118.html\" target=\"_blank\" rel=\"noopener\">s\u00edtio Web<\/a>.\u00a0<\/em><\/p>\n<p><span class=\"xn-location\">THOUSAND OAKS, Calif.<\/span>,\u00a0<span class=\"xn-chron\">Nov. 12, 2018<\/span>\u00a0\/PRNewswire\/ &#8212;\u00a0Amgen (NASDAQ:\u00a0<a href=\"http:\/\/studio-5.financialcontent.com\/prnews?Page=Quote&amp;Ticker=AMGN\" target=\"_blank\" rel=\"noopener\">AMGN<\/a>) today announced that the Amgen Foundation has pledged\u00a0<span class=\"xn-money\">$500,000<\/span>\u00a0to support victims of the local wildfires in\u00a0<span class=\"xn-location\">Ventura<\/span>\u00a0e\u00a0<span class=\"xn-location\">Los Angeles<\/span>\u00a0Counties. The Amgen Foundation will select recipient non-profit organizations based on relief effort needs. In addition, the Amgen Foundation has committed\u00a0<span class=\"xn-money\">$250,000<\/span>\u00a0to the Ventura County Community Foundation&#8217;s Conejo Valley Victims Fund to support the victims, families and organizations providing support after the recent\u00a0<span class=\"xn-location\">Milhoes de Oaks<\/span>\u00a0shooting tragedy.<\/p>\n<p>&#8220;Our community has endured significant tragedy with the recent senseless nightclub shooting, as well as another series of wildfires that have resulted in devastating damage and impact to our staff. We are committed to assisting in relief and support efforts and applaud the firefighters and first responders who are working tirelessly to protect and serve our communities,&#8221; said\u00a0<span class=\"xn-person\">Cynthia M. Patton<\/span>, chief compliance officer at Amgen and chair of the Amgen Foundation Board of Directors.<\/p>\n<p>The Amgen Foundation will also match donations made by Amgen staff around the globe who wish to contribute their own funds to qualifying relief efforts and the Conejo Valley Victims Fund.<\/p>\n<p><b>About the Amgen Foundation<br class=\"dnr\" \/><\/b>The Amgen Foundation seeks to advance excellence in science education to inspire the next generation of innovators, and invest in strengthening communities where Amgen staff members live and work. To date, the Foundation has donated over\u00a0<span class=\"xn-money\">$250 million<\/span>\u00a0to local, regional, and international nonprofit organizations that impact society in inspiring and innovative ways. The Amgen Foundation brings the excitement of discovery to the scientists of tomorrow through several signature programs, including Amgen Scholars, Amgen Biotech Experience, and Amgen Teach. For more information, visit\u00a0<a href=\"http:\/\/www.amgeninspires.com\/\" rel=\"nofollow noopener\" target=\"_blank\">www.AmgenInspires.com<\/a>\u00a0and follow us on Twitter @AmgenFoundation.<\/p>\n<p><b>About Amgen<\/b>\u00a0<br class=\"dnr\" \/>Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.<\/p>\n<p>Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people&#8217;s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world&#8217;s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.<\/p>\n<p>Para mais informa\u00e7\u00f5es, visitar\u00a0<a href=\"http:\/\/www.amgen.com\/\" rel=\"nofollow noopener\" target=\"_blank\">www.amgen.com<\/a>\u00a0and follow us on<b>\u00a0<\/b><a href=\"http:\/\/www.twitter.com\/amgen\" target=\"_blank\" rel=\"nofollow noopener\">www.twitter.com\/amgen<\/a><b>.<\/b><\/p>\n<p>CONTACT: Amgen,\u00a0<span class=\"xn-location\">Milhoes de Oaks<\/span><br class=\"dnr\" \/><span class=\"xn-person\">Kristen Davis<\/span>, 805-447-3008 (Media)<br class=\"dnr\" \/><span class=\"xn-person\">Kristen Neese<\/span>, 805-313-8267 (Media)<\/p>\n<p>SOURCE Amgen<\/p>\n<h4>Related Links<\/h4>\n<p><a class=\"linkOnClick\" title=\"Link to http:\/\/www.amgen.com\" href=\"http:\/\/www.amgen.com\/\" target=\"_blank\" rel=\"nofollow noopener\">http:\/\/www.amgen.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":8375,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"give_campaign_id":0,"footnotes":""},"categories":[22],"tags":[],"class_list":["post-8374","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-coverage"],"acf":[],"_links":{"self":[{"href":"https:\/\/vccf.org\/pt\/wp-json\/wp\/v2\/posts\/8374","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vccf.org\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vccf.org\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vccf.org\/pt\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vccf.org\/pt\/wp-json\/wp\/v2\/comments?post=8374"}],"version-history":[{"count":0,"href":"https:\/\/vccf.org\/pt\/wp-json\/wp\/v2\/posts\/8374\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vccf.org\/pt\/wp-json\/wp\/v2\/media\/8375"}],"wp:attachment":[{"href":"https:\/\/vccf.org\/pt\/wp-json\/wp\/v2\/media?parent=8374"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vccf.org\/pt\/wp-json\/wp\/v2\/categories?post=8374"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vccf.org\/pt\/wp-json\/wp\/v2\/tags?post=8374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}